image credit: Freepik

Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy

May 17, 2023

Two and a half years ago, Nicole Paulk’s coworkers told her to start a company. The gene therapy researcher and then University of California, San Francisco assistant professor had just showed them data from mice studies testing a new kind of cancer treatment her lab was developing, and they were impressed.

The presentation was internal, to physicians and researchers, but the positive feedback led Paulk to visit the university’s entrepreneurship center the same day.

Read More on Biopharma Dive